Skip to content

ABX Pentra 60 Hematology Analyzer

by Abx Diagnostics

510(k) K992511

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None ongoing

1 closed

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK992511 Date15 Oct 1999ClearedStatusActive

Recalls

1 recall · FDA

    • Terminated Z-0039-04 FDA Unclassified (pre-2012) initiated 8 Sep 2003

    Samples with high fat content will not count platelets accurately.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA Product Code
GKZ
Device Class
Class II
Regulation
21 CFR Part 864.5220
Advisory Committee
Hematology
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 19 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The ABX Pentra 60 Hematology Analyzer is a Counter, Differential Cell device designed for automated hematological analysis. It performs complete blood counts (CBC) and five-part leukocyte differentials, utilizing cytochemistry and light absorbency to classify white blood cells. The system is engineered to process whole blood samples with minimal volume requirements, enhancing efficiency in clinical diagnostics.

This analyzer is intended for use in clinical laboratories and healthcare settings, operating as a standalone instrument with data management capabilities via a connected PC. Supplied as a reusable medical device, it requires proper calibration and maintenance as outlined in manufacturer guidelines. The ABX Pentra 60 holds FDA 510K clearance under the classification of Class II, adhering to regulatory standards for hematology analyzers.

Other devices from Abx Diagnostics

See all devices from Abx Diagnostics →

Questions

AI-generated answers, 19 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What types of blood tests can the ABX Pentra 60 Hematology Analyzer perform, and how does it classify white blood cells?

    The ABX Pentra 60 performs complete blood counts (CBC) and five-part leukocyte differentials. It classifies white blood cells using cytochemistry and light absorbency, which helps distinguish between different types of leukocytes for accurate diagnostic results.

  • Is the ABX Pentra 60 Hematology Analyzer designed for single-use or reusable applications, and what maintenance does it require?

    The ABX Pentra 60 is a reusable medical device, meaning it is intended for repeated use in clinical settings. Like all reusable devices, it requires proper calibration and maintenance as outlined by the manufacturer to ensure accurate and reliable performance over time.

  • What regulatory pathway was followed for the FDA clearance of the ABX Pentra 60 Hematology Analyzer?

    The ABX Pentra 60 received FDA clearance through a 510(k) premarket notification, specifically under the Traditional 510(k) review pathway. It was determined to be substantially equivalent to a predicate device and falls under Class II regulatory classification for hematology analyzers.

  • How is the ABX Pentra 60 intended to be integrated into a clinical workflow, and what connectivity does it offer?

    The ABX Pentra 60 is designed as a standalone instrument for clinical laboratories and healthcare settings. It connects to a PC for data management, allowing seamless integration into existing workflows for automated hematological analysis and result reporting.